SELLAS Life Sciences Gr (NASDAQ:SLS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does SELLAS Life Sciences Gr (SLS) operate in?

SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SELLAS Life Sciences Gr Stock (NASDAQ: SLS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	385.00 / 658.01K
Day Range	- - -
52 Wk Range	0.50 - 1.90
Market Cap	$78.49M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	12.8%
Days to Cover	16.75

Recent News

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Galena Biopharma Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Galena Biopharma, Inc. (NASDAQ: SLS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

Zacks

Dow Falls Over 200 Points; Adobe Shares Plunge

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded down 0.55% to 38,692.43 while the NASDAQ fell 0.90% to 15,982.65. The S&P 500 also fell, dropping, 0.64% to 5,117.35.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	385.00 / 658.01K
Day Range	- - -
52 Wk Range	0.50 - 1.90
Market Cap	$78.49M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	12.8%
Days to Cover	16.75

About SELLAS Life Sciences Group Inc

Sector

Health Care

Industry

Biotechnology

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SELLAS Life Sciences Gr (SLS) stock?

You can purchase shares of SELLAS Life Sciences Gr (NASDAQ:SLS) through any online brokerage.

View our list of the best stock brokerages

Who are SELLAS Life Sciences Gr (SLS) competitors?

Other companies in SELLAS Life Sciences Gr’s space includes: Renovaro (NASDAQ:RENB), Cellectar Biosciences (NASDAQ:CLRB), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).

What is the forecast, or price target, for SELLAS Life Sciences Gr (SLS) stock?

SELLAS Life Sciences Gr has a consensus price target of $5.50.

What is the current price for SELLAS Life Sciences Gr (SLS)?

The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $1.22 last updated September 25, 2024 at 7:42 AM EDT.

Does SELLAS Life Sciences Gr (SLS) pay a dividend?

There are no upcoming dividends for SELLAS Life Sciences Gr.

When is SELLAS Life Sciences Gr (NASDAQ:SLS) reporting earnings?

SELLAS Life Sciences Gr’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is SELLAS Life Sciences Gr (SLS) going to split?

There is no upcoming split for SELLAS Life Sciences Gr.

What sector and industry does SELLAS Life Sciences Gr (SLS) operate in?

SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge